53
Participants
Start Date
December 22, 2020
Primary Completion Date
February 14, 2025
Study Completion Date
February 14, 2025
Darvadstrocel
Darvadstrocel suspension of human expanded adipose stem cells.
Akh Wien, Vienna
Klinikum Dresden, University Hospital Dresden, Dresden
CHU de Nice - Hopital de l'Archet II - Gastro-Enterologie, Hepatologi, Nice
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Hospital Universitari de Bellvitge, Barcelona
Charite - Campus Benjamin Franklin, Berlin
Krankenhaus Waldfriede, Berlin
H. Donostia, Donostia / San Sebastian
Stadtisches Klinikum Luneburg, Luneburg
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario La Paz, Madrid
CHRU Hopital de Pontchaillou - Maladies De L'Appareil Digesti, Rennes
C.H.U. de Pontevedra, Pontevedra
Hospital Universitario Nuestra Senora de la Candelaria, Santa Cruz de Tenerife
H.C.U. de Valencia, Valencia
Hospital Universitari i Politecnic La Fe, Valencia
Rabin Medical Center, Beilinson Hospital, Petah Tikva
CHRU de Lille - Hopital Claude Huriez - Gastroenterologie, Lille
Tel Aviv Sourasky Medical Center, Tel Aviv
Centre Hospitalier Lyon Sud - Gastroenterology, Pierre-Bénite
Paris St. Joseph Hospital, Paris
Groupe Hospitalier Diaconesses Croix Saint Simon, Paris
CHU AMIENS PICARDIE Site SUD Hepato-Gastroenterology, Amiens
Hadassah Medical Organization, Hadassah Medical Center, Ein-Karem, Jerusalem
Chaim sheba Medical Center, Tel Litwinsky
Shaare Zedek Medical Center, Jerusalem
NH Hospital a.s., Hořovice
ISCARE a.s., Prague
Hospital Universitario Son Espases, Palma de Mallorca
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Takeda
INDUSTRY